Evidence map›Paper›PMID 37887085›Full record

ArticleClinics and practice2023

Quality of Life among Peritoneal and Hemodialysis Patients: A Cross-Sectional Study.

Fadel AlRowaie, Abdullah Alaryni, Abdullah AlGhamdi, Renad Alajlan, Razan Alabdullah, Raed Alnutaifi, Raneem Alnutaifi, Amani Aldakheelallah, Alanoud Alshabanat, Abdullah Bin Shulhub and 4 more

Open access · goldAbstract read
In one paragraph

Article in Clinics and practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Fadel AlRowaieNephrology Department, King Fahad Medical City, Riyadh 12231, Saudi Arabia.ORCID 0000-0003-0528-3401
Abdullah AlaryniCollege of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh 11623, Saudi Arabia.
Abdullah AlGhamdiCollege of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh 11623, Saudi Arabia.
Renad AlajlanCollege of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh 11623, Saudi Arabia.ORCID 0009-0009-4736-6660
Razan AlabdullahCollege of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh 11623, Saudi Arabia.
Raed AlnutaifiCollege of Medicine, King Saud University, Riyadh 11451, Saudi Arabia.
Raneem AlnutaifiCollege of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh 11623, Saudi Arabia.
Amani AldakheelallahCollege of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh 11623, Saudi Arabia.
Alanoud AlshabanatCollege of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh 11623, Saudi Arabia.
Abdullah Bin ShulhubCollege of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh 11623, Saudi Arabia.
Othillah MoazinCollege of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh 11623, Saudi Arabia.
Rayan QutobCollege of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh 11623, Saudi Arabia.ORCID 0000-0002-1323-3191
Enad AlsolamiDepartment of Internal Medicine, College of Medicine, University of Jeddah, Jeddah P.O. Box 45311, Saudi Arabia.ORCID 0000-0002-3650-7626
Osamah HakamiCollege of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh 11623, Saudi Arabia.ORCID 0000-0002-0242-8305
Imam Mohammad ibn Saud Islamic University · SAKing Fahd Medical City · SAUniversity of Jeddah · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe quality of life (QoL) of patients with end-stage kidney disease (ESKD) who undergo dialysis is a reliable predictor of their long-term survival. Hemodialysis is the most common form of kidney replacement therapy for ESKD, followed by peritoneal dialysis. This study aimed to identify the factors affecting QoL in ESKD patients treated with peritoneal dialysis (PD) or hemodialysis (HD) in Riyadh, Saudi Arabia.

methodsA cross-sectional study was conducted between June and July 2021 to assess the QoL of patients with ESKD who underwent peritoneal dialysis and hemodialysis. Patients who had been on dialysis for at least one year were included. The Arabic version of the Quality of Life Index-Dialysis (QLI-D) version III was used to measure the QoL.

resultsA total of 210 patients completed the questionnaire. The overall QLI score was 21.73 ± 4.2, with subscales for health and functioning (20.35 ± 5.2), social and economic (20.20 ± 4.8), psychological/spiritual (23.94 ± 4.9), and family (24.95 ± 4.5). The QLI scores for PD and HD patients were 21.80 ± 4.4 and 21.72 ± 4.1, respectively. SOCSUB (

conclusionThe study found that patients were most satisfied with their family, health and functioning, and social/economic subscales. Income and years of dialysis were found to be predictive factors of QoL. Overall, peritoneal patients in this study demonstrated a better QoL than HD patients.

Indexed as

cross-sectional studyhemodialysiskidney disease quality of lifeperitoneal dialysisSaudi Arabia

Identifiers

PMID37887085
PMCPMC10605737
OpenAlexW4387293815

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.